Filing Details

Accession Number:
0001140361-10-021279
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-14 13:00:00
Reporting Period:
2010-05-12
Filing Date:
2010-05-14
Accepted Time:
2010-05-14 14:28:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401782 Mark Wood C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-12 5,300 $0.00 13,381 No 4 A Direct
Common Stock Disposition 2010-05-13 546 $21.75 12,835 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2010-05-12 40,000 $0.00 40,000 $21.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
160,668 2010-11-12 2020-05-11 No 4 A Direct
Footnotes
  1. Restricted stock units granted on May 12, 2010. Price not applicable.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $21.613 to $21.827. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter.